CCA
AGN

Column Capital Advisors’s Allergan plc AGN Stock Holding History

Column Capital Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-43
Closed -$8K – 947
2020
Q1 		$8K Hold
43
– – ﹤0.01% 433
2019
Q4 		$8K Buy
+43
New +$7.76K ﹤0.01% 482

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Column Capital Advisors's AGN Position: Q2 2020 in Review

Column Capital Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 43 shares — an estimated $8K sold.

Column Capital Advisors first reported a position in AGN in Q4 2019 and held it in 2 quarters. The position peaked at $8K in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Column Capital Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Column Capital Advisors sold 43 Allergan plc shares in Q2 2020, an estimated $8K.
  • Column Capital Advisors first reported a position in Allergan plc in Q4 2019 and held it in 2 quarters.
  • Column Capital Advisors's Allergan plc position peaked at $8K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Column Capital Advisors's 13F filing for Q2 2020, filed 12 Aug 2020.